Abn Amro Investment Solutions Organon & Co. Transaction History

Abn Amro Investment Solutions

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Sep 05, 2025	SELL	$16.59 - $23.77 $2.79 Million - $3.99 Million	-167,931 Closed	0 $0
Q2 2023 Sep 05, 2025	SELL	$19.27 - $24.63 $985,448 - $1.26 Million	-51,139 Reduced 23.34%	167,931 $3.49 Billion
Q1 2023 Sep 05, 2025	BUY	$21.42 - $32.08 $4.69 Million - $7.03 Million	219,070 New	219,070 $5.15 Billion

788

197M

2.5M

2.94M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $1.92B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

Stay updated on Abn Amro Investment Solutions with notifications on news.